PRKCA and prostate carcinoma: Examination of PKCα expression in established prostate cancer cell models showed a prominent upregulation in PC3, PC3-ML, and DU145 prostate cancer cell lines compared with less aggressive LNCaP cells and its sublines (C4, C4-2) or 22RV1 cells (Fig. 1A).